Uniphar (UPR) Competitors GBX 214 +1.00 (+0.47%) (As of 07:32 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividend UPR vs. UDG, ONT, GNS, CLIN, EMIS, VEC, SPI, CTH, INDV, and ERGOShould you be buying Uniphar stock or one of its competitors? The main competitors of Uniphar include UDG Healthcare (UDG), Oxford Nanopore Technologies (ONT), Genus (GNS), Clinigen Group (CLIN), EMIS Group (EMIS), Vectura Group (VEC), Spire Healthcare Group (SPI), CareTech (CTH), Indivior (INDV), and Ergomed (ERGO). These companies are all part of the "medical" sector. Uniphar vs. UDG Healthcare Oxford Nanopore Technologies Genus Clinigen Group EMIS Group Vectura Group Spire Healthcare Group CareTech Indivior Ergomed Uniphar (LON:UPR) and UDG Healthcare (LON:UDG) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, community ranking, dividends, valuation, earnings, analyst recommendations, media sentiment, risk and institutional ownership. Is UPR or UDG more profitable? Uniphar has a net margin of 1.69% compared to UDG Healthcare's net margin of 0.00%. Uniphar's return on equity of 13.91% beat UDG Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Uniphar1.69% 13.91% 3.76% UDG Healthcare N/A N/A N/A Which has higher earnings and valuation, UPR or UDG? Uniphar has higher revenue and earnings than UDG Healthcare. UDG Healthcare is trading at a lower price-to-earnings ratio than Uniphar, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUniphar£2.68B0.21£45.17M£0.141,500.00UDG Healthcare£1.25B2.18N/A£25.4042.48 Does the MarketBeat Community favor UPR or UDG? UDG Healthcare received 513 more outperform votes than Uniphar when rated by MarketBeat users. However, 100.00% of users gave Uniphar an outperform vote while only 74.68% of users gave UDG Healthcare an outperform vote. CompanyUnderperformOutperformUnipharOutperform Votes6100.00% Underperform VotesNo VotesUDG HealthcareOutperform Votes51974.68% Underperform Votes17625.32% Do analysts rate UPR or UDG? Uniphar currently has a consensus price target of GBX 310, suggesting a potential upside of 47.62%. Given Uniphar's higher probable upside, analysts plainly believe Uniphar is more favorable than UDG Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Uniphar 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00UDG Healthcare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Do institutionals and insiders believe in UPR or UDG? 45.9% of Uniphar shares are owned by institutional investors. 10.1% of Uniphar shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is UPR or UDG a better dividend stock? Uniphar pays an annual dividend of GBX 2 per share and has a dividend yield of 1.0%. UDG Healthcare pays an annual dividend of GBX 0.17 per share and has a dividend yield of 0.0%. Uniphar pays out 1,428.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. UDG Healthcare pays out 0.7% of its earnings in the form of a dividend. Does the media prefer UPR or UDG? In the previous week, UDG Healthcare's average media sentiment score of 0.45 beat Uniphar's score of 0.00 indicating that UDG Healthcare is being referred to more favorably in the news media. Company Overall Sentiment Uniphar Neutral UDG Healthcare Neutral SummaryUniphar beats UDG Healthcare on 11 of the 16 factors compared between the two stocks. Ad Priority GoldBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...Get your free information kit NOW, before it's too late. Get Uniphar News Delivered to You Automatically Sign up to receive the latest news and ratings for UPR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding UPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat are MarkeBeat Followers?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPR vs. The Competition Export to ExcelMetricUnipharMedical Distribution IndustryMedical SectorLON ExchangeMarket Cap£573.34M£19.51B£5.46B£1.39BDividend Yield0.72%1.19%4.39%11.71%P/E Ratio1,500.00104.70104.851,558.01Price / Sales0.2160.181,234.02178,521.79Price / Cash9.9711.9637.9832.90Price / Book1.642.144.702.83Net Income£45.17M£1.15B£114.72M£152.69M7 Day Performance-0.94%-0.17%-0.92%-0.15%1 Month Performance-4.55%125.57%14.17%2.60%1 Year Performance12.30%-5.20%23.82%93.00% Uniphar Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPRUnipharN/AGBX 214+0.5%GBX 310+44.9%+10.5%£584.26M£2.68B1,528.573,000UDGUDG HealthcareN/AGBX 1,079flatN/AN/A£2.72B£1.25B42.489,000ONTOxford Nanopore Technologies2.362 of 5 starsGBX 146.07-3.1%GBX 235.50+61.2%-25.9%£1.37B£167.75M-730.331,238GNSGenus1.003 of 5 starsGBX 2,055-4.6%GBX 2,150+4.6%-7.0%£1.35B£668.80M17,125.00480News CoverageCLINClinigen GroupN/AGBX 925flatN/A+0.0%£1.23B£565.60M64.691,000News CoverageEMISEMIS GroupN/AGBX 1,920flatN/A+0.3%£1.23B£176.86M4,085.111,560VECVectura GroupN/AGBX 164.80flatN/AN/A£1.01B£190.60M8.209,200SPISpire Healthcare Group2.6163 of 5 starsGBX 227-0.9%GBX 301.33+32.7%+4.6%£916.67M£1.44B3,242.86420CTHCareTechN/AGBX 750+0.3%N/A+0.0%£850.02M£495.40M10,714.2911,000News CoverageINDVIndivior2.9133 of 5 starsGBX 579.20-19.4%GBX 1,500+159.0%-65.4%£750.47M£1.15B-742.561,000News CoveragePositive NewsERGOErgomedN/AGBX 1,346flatN/A+0.3%£701.00M£152.09M4,641.386 Related Companies and Tools Related Companies: UDG Alternatives ONT Alternatives GNS Alternatives CLIN Alternatives EMIS Alternatives VEC Alternatives SPI Alternatives CTH Alternatives INDV Alternatives ERGO Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:UPR) was last updated on 10/11/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBigger Than Nvidia?Bigger Than Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the n...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Uniphar plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Uniphar With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.